Holen Sie sich die Stockscreener-App
9.47
0.53%
-0.05
Schlusskurs vom Vortag:
$9.52
Offen:
$9.57
24-Stunden-Volumen:
61,385
Relative Volume:
0.42
Marktkapitalisierung:
$136.57M
Einnahmen:
$166.88M
Nettoeinkommen (Verlust:
$-74.18M
KGV:
-1.8679
EPS:
-5.07
Netto-Cashflow:
$1.14M
1W Leistung:
-0.63%
1M Leistung:
+0.53%
6M Leistung:
-13.91%
1J Leistung:
-41.62%
1-Tages-Spanne:
$9.47
$9.60
1-Wochen-Bereich:
$9.155
$9.60
52-Wochen-Spanne:
$7.8701
$18.37
Anika Therapeutics Inc Stock (ANIK) Company Profile
Firmenname
Anika Therapeutics Inc
Sektor
Telefon
(781) 457-9000
Adresse
32 WIGGINS AVENUE, BEDFORD, MA
Vergleichen Sie ANIK mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ANIK
Anika Therapeutics Inc
|
9.47 | 137.29M | 166.88M | -74.18M | 1.14M | -5.07 |
|
ZTS
Zoetis Inc
|
124.02 | 55.12B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.96 | 50.80B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
10.26 | 45.60B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
31.64 | 36.04B | 16.88B | 666.71M | 251.19M | 0.6132 |
|
UTHR
United Therapeutics Corp
|
471.01 | 20.23B | 3.08B | 1.24B | 1.07B | 25.61 |
Anika Therapeutics Inc Stock (ANIK) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-04-17 | Eingeleitet | B. Riley Securities | Buy |
| 2024-11-01 | Bestätigt | Barrington Research | Outperform |
| 2023-08-14 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
| 2023-03-07 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2022-11-09 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
| 2022-10-14 | Fortgesetzt | Stephens | Equal-Weight |
| 2022-03-09 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2022-03-09 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2021-11-16 | Eingeleitet | Stephens | Overweight |
| 2021-07-16 | Eingeleitet | UBS | Neutral |
| 2020-12-16 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
| 2020-05-08 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2020-01-21 | Hochstufung | Sidoti | Neutral → Buy |
| 2020-01-10 | Hochstufung | First Analysis Sec | Outperform → Strong Buy |
| 2019-11-05 | Eingeleitet | BWS Financial | Sell |
| 2019-09-24 | Bestätigt | Barrington Research | Outperform |
| 2019-09-23 | Herabstufung | First Analysis Sec | Strong Buy → Outperform |
| 2019-07-25 | Hochstufung | First Analysis Sec | Neutral → Strong Buy |
| 2019-02-22 | Herabstufung | First Analysis Sec | Outperform → Neutral |
| 2019-02-22 | Herabstufung | Sidoti | Buy → Neutral |
| 2018-07-27 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
| 2018-06-20 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2018-06-20 | Herabstufung | First Analysis Sec | Overweight → Equal-Weight |
| 2018-05-04 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
| 2018-02-23 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2018-01-24 | Hochstufung | First Analysis Sec | Equal-Weight → Overweight |
| 2017-10-27 | Bestätigt | Barrington Research | Outperform |
| 2016-05-09 | Hochstufung | Singular Research | BUY - Long-Term → Buy |
| 2016-04-27 | Herabstufung | Northland Capital | Outperform → Market Perform |
| 2016-02-26 | Bestätigt | Barrington Research | Outperform |
Alle ansehen
Anika Therapeutics Inc Aktie (ANIK) Neueste Nachrichten
(ANIK) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
Can Anika Therapeutics Inc. stock withstand economic slowdownJuly 2025 Action & Growth Oriented Trade Recommendations - bollywoodhelpline.com
How Anika Therapeutics Inc. stock performs in rising dollar environmentFed Meeting & Smart Allocation Stock Tips - bollywoodhelpline.com
Anika Therapeutics (NASDAQ:ANIK) Share Price Passes Above 200-Day Moving AverageTime to Sell? - MarketBeat
Anika Therapeutics Builds Focused Platform For Joint Health Care - Kalkine Media
Will Anika Therapeutics Inc. stock benefit from infrastructure spendingMarket Risk Report & Long Hold Capital Preservation Plans - ulpravda.ru
Anika Therapeutics (NASDAQ:ANIK) Given “Outperform” Rating at Barrington Research - Defense World
(ANIK) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
Barrington Research Reiterates Outperform Rating for Anika Therapeutics (NASDAQ:ANIK) - MarketBeat
Anika Therapeutics (ANIK): Barrington Research Maintains Outperf - GuruFocus
Anika Therapeutics names Stephen Griffin as new CEO - Investing.com
Is Anika Therapeutics Inc. stock trading near support levels2025 Key Lessons & Risk Controlled Swing Alerts - Улправда
Anika Therapeutics Announces CEO Transition and Governance Changes - TipRanks
Will Anika Therapeutics Inc. (AKP) stock see insider accumulationMarket Sentiment Report & Growth Focused Stock Pick Reports - ulpravda.ru
Anika Therapeutics Announces Leadership Transition - Ortho Spine News
Is Anika Therapeutics Inc. (AKP) stock inflation resilientJuly 2025 PreEarnings & Growth Oriented Trade Recommendations - Улправда
How Anika Therapeutics Inc. stock reacts to inflationary pressuresJuly 2025 Review & Expert Verified Stock Movement Alerts - Улправда
Anika Therapeutics, Inc. Announces Chief Executive Officer Changes - MarketScreener
Anika Therapeutics names Stephen Griffin as new CEO By Investing.com - Investing.com Australia
Cosmetic Surgery Market Is Booming Worldwide 2025-2032 | - openPR.com
Anika Therapeutics Shares Plunge 27.42% After Clinical Trial Results Fail to Meet Primary Endpoints - Intellectia AI
Why Anika Therapeutics Inc. stock remains on watchlistsMarket Activity Report & Community Trade Idea Sharing - Улправда
Market Pulse: Why Anika Therapeutics Inc. stock is trending among retail tradersDip Buying & Daily Technical Forecast Reports - Улправда
Is Anika Therapeutics Inc. stock attractive for retirement portfolios2025 AllTime Highs & Low Risk Entry Point Guides - DonanımHaber
Why Anika Therapeutics Inc. stock could see breakout soonWeekly Investment Recap & Capital Protection Trading Alerts - DonanımHaber
Regenerative Medicine (Bone and Joint) Market Is Going to Boom | Anika Therapeutics, Inc, Arthrex, Inc. - openPR.com
Why Anika Therapeutics Inc. stock is trending among retail tradersQuarterly Profit Review & Expert Curated Trade Setup Alerts - Улправда
(ANIK) and the Role of Price-Sensitive Allocations - news.stocktradersdaily.com
Income Plays: Why Anika Therapeutics Inc. stock is trending among retail tradersJuly 2025 Macro Moves & Fast Gaining Stock Strategy Reports - Улправда
Anika Therapeutics’ Earnings Call: Growth Amid Challenges - MSN
Is the Options Market Predicting a Spike in Anika Therapeutics Stock? - sharewise.com
Is Anika Therapeutics Inc a good long term investmentTechnical Analysis Insights & Unlock Free Weekly Portfolio Checkups - earlytimes.in
Europe Viscosupplementation Market Detailed In New Research - openPR.com
Responsive Playbooks and the ANIK Inflection - Stock Traders Daily
Anika Therapeutics, Inc. INVESTIGATION: Kirby McInerney LLP - GlobeNewswire
What is the fair value estimate for Anika Therapeutics Inc. (AKP) stock in 2025CEO Change & Weekly Return Optimization Alerts - Newser
Can Anika Therapeutics Inc. (AKP) stock ride next bull market cycleIPO Watch & Short-Term Swing Trade Alerts - Newser
Dermal Fillers Market Size Report 2032 | AbbVie Inc., Galderma, - openPR.com
Are Investors Undervaluing Anika Therapeutics, Inc. (NASDAQ:ANIK) By 39%? - Yahoo Finance
Why Anika Therapeutics Inc. (AKP) stock stays on top picksQuarterly Investment Review & Low Drawdown Momentum Ideas - Newser
Is Anika Therapeutics Inc. stock a buy before product launchesJuly 2025 EndofMonth & Verified Technical Signals - Newser
Anika Therapeutics (ANIK) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
How Anika Therapeutics Inc. stock reacts to global recession fears2025 Earnings Impact & Weekly Market Pulse Updates - Newser
United States Joint Pain Injection Market Surges at 12% CAGR - openPR.com
Understanding the Setup: (ANIK) and Scalable Risk - news.stocktradersdaily.com
Anika Therapeutics Inc.Common Stock (NQ: ANIK - Markets Financial Content
Osteoarthritis Therapeutics Market Key PlayersShare Consolidation Trends & Capital Growth Signals - openPR.com
Anika Therapeutics Reports Mixed Q3 2025 Results - MSN
How Anika Therapeutics Inc. stock responds to policy changes2025 Momentum Check & Reliable Intraday Trade Plans - newser.com
Envestnet Asset Management Inc. Boosts Stake in Anika Therapeutics Inc. $ANIK - Defense World
How Anika Therapeutics Inc. (AKP) stock reacts to Fed tighteningMarket Volume Report & Smart Money Movement Alerts - newser.com
Finanzdaten der Anika Therapeutics Inc-Aktie (ANIK)
Umsatz
Nettogewinn
Free Cashflow
ENV
Anika Therapeutics Inc-Aktie (ANIK) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Nunes Anne | SVP, Chief Operations Officer |
Mar 17 '25 |
Option Exercise |
0.00 |
3,637 |
0 |
21,722 |
| Colleran David | EVP, General Counsel, Corp Sec |
Mar 17 '25 |
Option Exercise |
0.00 |
6,448 |
0 |
49,847 |
| Blanchard Cheryl R | President, CEO, Director |
Mar 17 '25 |
Option Exercise |
0.00 |
25,132 |
0 |
209,472 |
| Nunes Anne | SVP, Chief Operations Officer |
Mar 11 '25 |
Option Exercise |
0.00 |
2,561 |
0 |
18,837 |
| Colleran David | EVP, General Counsel, Corp Sec |
Mar 11 '25 |
Option Exercise |
0.00 |
7,663 |
0 |
45,649 |
| Blanchard Cheryl R | President, CEO, Director |
Mar 11 '25 |
Option Exercise |
0.00 |
30,060 |
0 |
197,015 |
| Nunes Anne | SVP, Chief Operations Officer |
Mar 10 '25 |
Option Exercise |
0.00 |
3,296 |
0 |
17,235 |
| Colleran David | EVP, General Counsel, Corp Sec |
Mar 10 '25 |
Option Exercise |
0.00 |
5,465 |
0 |
39,590 |
| Blanchard Cheryl R | President, CEO, Director |
Mar 10 '25 |
Option Exercise |
0.00 |
20,002 |
0 |
172,826 |
3.40%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):